Intestinal dysbiosis fuels liver disease progression via NLRP3 in the Mdr2-/- mouse model of primary sclerosing cholangitis

被引：0

作者：

Liao, Lijun ^{[1
,2
]}

Schneider, Kai Markus ^{[1
]}

Eric, Galvez ^{[3
]}

Frissen, Mick ^{[1
]}

Marschall, Hanns-Ulrich ^{[4
]}

Sun, Huan ^{[1
]}

Hatting, Maximilian ^{[1
]}

Wahlstroem, Annika ^{[4
]}

Haybaeck, Johannes ^{[5
,6
]}

Puchas, Philip ^{[6
]}

Mohs, Antje ^{[1
]}

Jin, Peng ^{[1
]}

Bergheim, Ina ^{[7
]}

Nier, Anika ^{[7
]}

Hennings, Julia ^{[1
]}

Reissing, Johanna ^{[1
]}

Wolfgang, Zimmermann Henning ^{[1
]}

Longerich, Thomas ^{[8
]}

Strowig, Till ^{[3
]}

Liedtke, Christian ^{[1
]}

Cubero, Francisco Javier ^{[1
,9
]}

Trautwein, Christian ^{[1
]}

机构：

[1] Univ Hosp RWTH Aachen, Dept Internal Med 3, Aachen, Germany

[2] Tongji Univ, Shanghai East Hosp, Dept Anesthesiol & Pain Management, Shanghai, Peoples R China

[3] Helmholtz Ctr Infect Res GmbH, Braunschweig, Germany

[4] Wallenberg Inst & Labs, Dept Mol & Clin Med, Gothenburg, Sweden

[5] Univ Magdeburg, Dept Pathol, Magdeburg, Germany

[6] Med Univ Graz, Dept Pathol, Graz, Austria

[7] Univ Vienna, Mol Nutr Sci Div, Dept Nutr Sci, Vienna, Austria

[8] Heidelberg Univ Hosp, Liver Canc Ctr Heidelberg, Heidelberg, Germany

[9] Univ Complutense Madrid, Sch Med, Dept Immunol, Madrid, Spain

来源：

JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期

关键词：

D O I：

10.1016/S0618-8278(19)30177-X

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

PS-159

引用

页码：E100 / E100

页数：1

共 50 条

[41] THE NOVEL AND SPECIFIC CHYMASE INHIBITOR, INVA8001, AMELIORATES THE PHENOTYPES OF PRIMARY SCLEROSING CHOLANGITIS (PSC) IN MDR2-/- MICE (MODEL OF PSC) BY DOWNREGULATION OF BILIARY SENESCENCE
Bernard, Jessie
Sharma, Sameer
Chawla, Meenakshi
Varma, Ashok
Kennedy, Lindsey
Zhou, Tianhao
Kundu, Debjyoti
Marakovits, Corinn N.
Chen, Lixian
Meyer, Alison A.
Smith, Leah
Ekser, Burcin
Ganjoo, Anita
Kant, Aman
Alesci, Okada Salvatore
Nandabalan, Krishnan
Alpini, Gianfranco
Francis, Heather L.
GASTROENTEROLOGY, 2023, 164 (06) : S1233 - S1233
[42] Human Placental Mesenchymal Stem Cells Relieve Primary Sclerosing Cholangitis via Upregulation of TGR5 in Mdr2-/- Mice and Human Intrahepatic Cholangiocyte Organoid Models
Yao, Qigu
Chen, Wenyi
Yu, Yingduo
Gao, Feiqiong
Zhou, Jiahang
Wu, Jian
Pan, Qiaoling
Yang, Jinfeng
Zhou, Lingling
Yu, Jiong
Cao, Hongcui
Li, Lanjuan
RESEARCH, 2023, 6
[43] Inhibition of H2 histamine receptor by Vivo-Morpholino treatment decreases mast cell activation, large biliary proliferation, angiogenesis, fibrosis and inflammation in the Mdr2-/- mouse model of primary sclerosing cholangitis
Kennedy, Lindsey
Demieville, Jennifer
Hargrove, Laura
Meng, Fanyin
Alpini, Gianfranco
Smith, Steven
Francis, Heather L.
HEPATOLOGY, 2017, 66 : 110A - 110A
[44] Inhibition of the substance P/neurokinin-1 receptor (NK-1R) axis decreases liver fibrosis in the Mdr2-/- mouse model of primary sclerosing cholangitis (PSC) through changes in senescence in cholangiocytes and hepatic stellate cells
Wan, Ying
Zhou, Tianhao
Wu, Nan
Invernizzi, Pietro
Standeford, Holly A.
McDaniel, Kelly
Bernuzzi, Francesca
Venter, Julie
Onori, Paolo
Gaudio, Eugenio
Franchitto, Antonio
Sato, Keisaku
Francis, Heather L.
Meng, Fanyin
Alpini, Gianfranco
Glaser, Shannon S.
HEPATOLOGY, 2016, 64 : 824A - 825A
[45] KNOCKOUT OF SECRETIN/SECRETIN RECEPTOR AXIS (SCT/SR) REDUCES LIVER FIBROSIS BY ANGIOGENESIS-DEPENDENT REDUCED SENESCENCE OF CHOLANGIOCYTES BUT INCREASED SENESCENCE OF HEPATIC STELLATE CELLS (HSCS) IN THE MDR2-/- MOUSE MODEL OF PRIMARY SCLEROSING CHOLANGITIS (PSC)
Zhou, Tianhao
Kyritsi, Konstantina
Wu, Nan
Venter, Julie
Francis, Heather L.
Meng, Fanyin
Chen, Lixian
Giang, Thao
White, Tori
Alpini, Gianfranco
Glaser, Shannon
GASTROENTEROLOGY, 2018, 154 (06) : S1185 - S1185
[46] Mast Cells Contribute to Hepatic Neurokinin1 Receptor Signaling, Subsequent Biliary Damage and Peribiliary Fibrosis Via TGF-β1 Signaling in MDR2-/- Mouse Model of Primary Scelrosing Cholangitis
Kundu, Debjyoti
Zhou, Tianhao
Meadows, Vik
Kennedy, Lindsey
Ceci, Ludovica
Kyritsi, Konstantina
Glaser, Shannon
Alpini, Gianfranco
Francis, Heather
FASEB JOURNAL, 2022, 36
[47] Add-on Norursodeoxycholic Acid Mitigates Liver Injury Induced By High Dose Ursodeoxycholic Monotherapy in the Mdr2 Knockout Mouse Model of Sclerosing Cholangitis
Halilbasic, Emina
Fuchs, Claudia Daniela
Auer, Thierry Claude Nicole
Leditznig, Nadja
Trauner, Michael H.
HEPATOLOGY, 2018, 68 : 871A - 872A
[48] KNOCKDOWN OF THE MT1 MELATONIN RECEPTOR AMELIORATES THE PHENOTYPES OF THE MDR2-/- MOUSE MODEL OF PRIMARY SCLEROSING CHOLANGITIS (PSC) BY DOWNREGULATION OF ORPHAN GPR50 RECEPTOR-PROMOTED CONSTITUTIVE TGF-β1 RECEPTOR SIGNALING
Wu, Nan
Ceci, Ludovica
Zhou, Tianhao
Francis, Heather L.
Kennedy, Lindsey
Kyritsi, Konstantina
Alvaro, Domenico
Carpino, Guido
Wu, Chaodong
Chakraborty, Sanjukta
Chen, Lixian
Baiocchi, Leonardo
Franchitto, Antonio
Ekser, Burcin
Onori, Paolo
Mancinelli, Romina
Grumbles, Kassidy
Gaudio, Eugenio
Glaser, Shannon S.
Alpini, Gianfranco
GASTROENTEROLOGY, 2021, 160 (06) : S768 - S768
[49] Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson’s disease
An-qi Dong
Ya-ping Yang
Shu-min Jiang
Xiao-yu Yao
Di Qi
Cheng-jie Mao
Xiao-yu Cheng
Fen Wang
Li-fang Hu
Chun-feng Liu
Acta Pharmacologica Sinica, 2023, 44 : 32 - 43
[50] Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson's disease
Dong, An-Qi
Yang, Ya-Ping
Jiang, Shu-Min
Yao, Xiao-Yu
Qi, Di
Mao, Cheng-Jie
Cheng, Xiao-Yu
Wang, Fen
Hu, Li-Fang
Liu, Chun-Feng
ACTA PHARMACOLOGICA SINICA, 2023, 44 (01) : 32 - 43

← 1 2 3 4 5 →